Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Coluracetam | Huperzine A | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 20-80 mg/day divided into 2-3 doses | 50-200 mcg twice daily |
| Timing | Morning and early afternoon. Sublingual administration may provide faster onset. With or without food. | Morning and early afternoon. With or without food. |
| Cycle Duration | Cycles of 4-8 weeks on, 2-4 weeks off | Cycle 2-4 weeks on, 1-2 weeks off to prevent AChE downregulation |
| Evidence Level | animal_plus_anecdotal | strong_human |
Enhances high-affinity choline uptake (HACU) via a unique mechanism distinct from other racetams — it increases HACU even in damaged cholinergic neurons, suggesting a choline uptake enhancement rather than mere stimulation. This HACU enhancement persists even after the compound has been cleared, indicating a lasting modification of choline transporter activity. Also shows affinity for AMPA receptors.
20-80 mg/day divided into 2-3 doses
Morning and early afternoon. Sublingual administration may provide faster onset. With or without food.
Cycles of 4-8 weeks on, 2-4 weeks off
Potent, selective, and reversible inhibitor of acetylcholinesterase (AChE), derived from the club moss Huperzia serrata. Exhibits preference for the tetrameric G4 form of AChE predominant in the mammalian brain. Eight-fold more potent than donepezil and two-fold more potent than rivastigmine at AChE inhibition. Crosses the BBB efficiently. Also antagonizes NMDA receptors at high concentrations and provides neuroprotection via attenuation of oxidative stress, regulation of apoptotic proteins (Bcl-2, Bax, P53, caspase-3), and upregulation of NGF.
50-200 mcg twice daily
Morning and early afternoon. With or without food.
Cycle 2-4 weeks on, 1-2 weeks off to prevent AChE downregulation
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →